soy isoflavone
Sponsors
Laboratoires Arkopharma, National Health Research Institutes, Taiwan, Northwestern University, Trisakti University, Emory University
Conditions
AsthmaAsthma in ChildrenCancer of Head and NeckCardiovascular DiseaseLow Bone DensityNAFLDOsteopeniaOsteoporosis
Phase 1
Phase 2
Phase 3
Unknown Phase
A Taiwan Isoflavone Multicenter Study (TIMS)
NCT00262184
Start: 2004-12-31End: 2007-12-31Target: 420Updated: 2005-12-06
Modification of Asthma With Soy Isoflavone
CompletedNCT00741208
Start: 2008-08-31End: 2010-11-30Updated: 2011-06-08
The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
NCT03773029
Start: 2019-01-01End: 2019-11-30Target: 47Updated: 2019-11-19
Isoflavones and Peritoneal Dialysis
CompletedNCT04185168
Start: 2019-11-16End: 2020-01-18Updated: 2020-02-06
The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A
CompletedNCT06101433
Start: 2022-09-06End: 2023-05-11Updated: 2023-10-26